アレルギー治療薬市場：タイプ別、治療法別、流通チャネル別-2025-2030年の世界予測

アレルギー治療薬市場は、2023年に297億1,000万米ドルと評価され、2024年には322億1,000万米ドルに達すると予測され、CAGR 8.48％で成長し、2030年には525億4,000万米ドルに達すると予測されています。

アレルギー治療薬の対象範囲には、抗ヒスタミン薬、コルチコステロイド、充血除去薬、エピネフリンなど、アレルギー反応の治療に使用される幅広い医薬品が含まれます。これらの薬剤は、季節性アレルギー、食物アレルギー、アレルギー性喘息など、さまざまなタイプのアレルギーに対応しています。これらの薬剤の必要性は、都市化、汚染レベルの上昇、食生活パターンの変化などを背景に、世界的にアレルギー有病率が上昇していることによって裏付けられています。アレルギー治療薬は、くしゃみ、かゆみ、腫れなどの症状を緩和するために、市販薬と処方薬の両方で使用されています。最終用途の分野には、病院、診療所、在宅介護の現場が含まれ、経口錠剤、点鼻薬、吸入器、ローションなどの様々な送達形態に支えられています。

市場の成長は、より新しく効果的なアレルギー治療に貢献するバイオテクノロジーや遺伝子研究の継続的な進歩などの要因に影響されます。さらに、認知度や診断率の向上も市場拡大を後押ししています。しかし、市場は、これらの薬剤の長期使用に伴う副作用、高度な薬剤の高コスト、新薬承認のための厳しい規制要件などの課題に直面しています。ヘルスケアのインフラが改善し、アレルギーに対する意識が高まっている新興市場への拡大には、潜在的なビジネスチャンスが存在します。免疫療法と生物学的製剤の革新は、企業が研究努力を傾注できる未開拓領域です。

企業は、遺伝的素因に基づいて特定のタイプのアレルギーを標的とする個別化医療のアプローチを探求することができます。さらに、自動注射器やナノテクノロジーに基づく送達システムなど、より効率的で患者に優しい投与方法など、送達メカニズムにも革新の余地があります。アレルギー治療薬市場は競争市場であり、ジェネリック医薬品とブランド医薬品の両方が市場シェアを争っています。新たなアレルゲンの特定や環境制御の改善に重点を置いた調査への取り組みは、市場をさらに強化し、ビジネスを大きく成長させる道を提供する可能性があります。市場の継続的拡大には、革新的な解決策でこうした限界や課題に対処することが不可欠です。

市場力学：急速に進化するアレルギー治療薬市場の主要市場インサイトを公開

アレルギー治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界のアレルギー有病率の増加
  • アレルギー専用薬の開発の増加
  • 市販薬志向の高まり
• 市場抑制要因
  • 特許切れとジェネリック医薬品との競合に対する懸念
• 市場機会
  • 免疫療法のイントロダクションと投与方法の増加
  • 食物アレルギーに対する消費者の意識の高まり
• 市場の課題
  • アレルギー治療薬の代替品の入手可能性

ポーターの5つの力：アレルギー治療薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：アレルギー治療薬市場における外部からの影響の把握

外部マクロ環境要因は、アレルギー治療薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析アレルギー治療薬市場における競合情勢の把握

アレルギー治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスアレルギー治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、アレルギー治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨アレルギー治療薬市場における成功への道筋を描く

アレルギー治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的にアレルギーの蔓延が増加
    • アレルギー特異薬の開発増加
    • 市販薬の普及率の上昇
  • 抑制要因
    • 特許切れとジェネリック医薬品との激しい競合に対する懸念
  • 機会
    • 免疫療法のイントロダクションと投与方法の発展
    • 食品アレルギーに対する消費者の意識の高まり
  • 課題
    • アレルギーに対する代替薬の入手可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 アレルギー治療薬市場：タイプ別

• 薬物アレルギー
• 食物アレルギー
• 吸入アレルギー

第7章 アレルギー治療薬市場治療別

• 抗アレルギー薬
  • 抗ヒスタミン薬
  • コルチコステロイド
  • ロイコトリエン阻害剤
• 免疫療法
  • 皮下免疫療法（SCIT）舌下免疫療法（SLIT）

第8章 アレルギー治療薬市場流通チャネル別

• 病院薬局
• オンライン薬局
• 小売薬局・ドラッグストア

第9章 南北アメリカのアレルギー治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のアレルギー治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのアレルギー治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Allergy Therapeutics PLC
• Astra Biotech GmbH
• AstraZeneca PLC
• Bayer AG
• GlaxoSmithKline PLC
• HAL Allergy B.V.
• Hikma Pharmaceuticals PLC
• Johnson & Johnson Services, Inc.
• LETI Pharma, S.L.U.
• Lupin Limited
• Mylan N.V. by Viatris Inc.
• Novartis AG
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.
• XOLAIR by F. Hoffmann-La Roche AG

LIST OF FIGURES

• FIGURE 1. ALLERGY DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. ALLERGY DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ALLERGY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ALLERGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ALLERGY DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ALLERGY DRUGS MARKET DYNAMICS
• TABLE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 40. CANADA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 42. CANADA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 43. CANADA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 44. CANADA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 67. CHINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. CHINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 69. CHINA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 70. CHINA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 71. CHINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 72. INDIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. INDIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 74. INDIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 75. INDIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 76. INDIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 112. THAILAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 138. FINLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 143. FRANCE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 148. GERMANY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 153. ISRAEL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 158. ITALY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ITALY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 160. ITALY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 161. ITALY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 162. ITALY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 163. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 168. NIGERIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 173. NORWAY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 178. POLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. POLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 180. POLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 181. POLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 182. POLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 183. QATAR ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. QATAR ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 185. QATAR ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 186. QATAR ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 187. QATAR ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 188. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 203. SPAIN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 208. SWEDEN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 213. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 218. TURKEY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 228. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 233. ALLERGY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 234. ALLERGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

The Allergy Drugs Market was valued at USD 29.71 billion in 2023, expected to reach USD 32.21 billion in 2024, and is projected to grow at a CAGR of 8.48%, to USD 52.54 billion by 2030.

The scope of allergy drugs encompasses a wide range of medications used to treat allergic reactions, including antihistamines, corticosteroids, decongestants, and epinephrine, among others. These drugs cater to various types of allergies such as seasonal allergies, food allergies, and allergic asthma. The necessity of these medications is underscored by the rising prevalence of allergies globally, driven by urbanization, increased pollution levels, and changing dietary patterns. In terms of application, allergy drugs are used in both over-the-counter and prescription forms to relieve symptoms like sneezing, itching, and swelling. End-use sectors include hospitals, clinics, and homecare settings, supported by a variety of delivery forms such as oral tablets, nasal sprays, inhalers, and lotions.

Market growth is influenced by factors like continuous advancements in biotechnology and genetic research, which contribute to newer and more effective allergy treatments. Additionally, growing awareness and diagnosis rates further enhance market expansion. However, the market faces challenges such as side effects associated with long-term usage of these drugs, high costs of advanced medications, and stringent regulatory requirements for new drug approval. Potential opportunities exist in expanding into emerging markets where healthcare infrastructures are improving and awareness around allergies is rising. Innovations in immunotherapy and biologic drugs represent untapped areas where companies could focus research efforts.

Companies could explore personalized medicine approaches to target specific types of allergies based on genetic predispositions. Additionally, there is room for innovation in delivery mechanisms, such as more efficient and patient-friendly administration methods like auto-injectors or nanotechnology-based delivery systems. The nature of the allergy drugs market is competitive, with both generic and branded drugs vying for market share. Initiatives in research focused on identifying new allergens and improving environmental controls could further bolster the market and provide avenues for significant business growth. Addressing these limitations and challenges with innovative solutions is crucial for continued market expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Allergy Drugs Market

The Allergy Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of allergy globally
  • Increasing development of allergy-specific drugs
  • Rise in prevalence towards over the counter drugs
• Market Restraints
  • Concerns over patent expiration and extensive competition from generic drugs
• Market Opportunities
  • Introduction of immunotherapy and development of increasing ways of administration
  • Rising consumer awareness on food allergies
• Market Challenges
  • Availability of alternative drugs for allergy

Porter's Five Forces: A Strategic Tool for Navigating the Allergy Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Allergy Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Allergy Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Allergy Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Allergy Drugs Market

A detailed market share analysis in the Allergy Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Allergy Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Allergy Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Allergy Drugs Market

A strategic analysis of the Allergy Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Allergy Drugs Market, highlighting leading vendors and their innovative profiles. These include Allergy Therapeutics PLC, Astra Biotech GmbH, AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., LETI Pharma, S.L.U., Lupin Limited, Mylan N.V. by Viatris Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., and XOLAIR by F. Hoffmann-La Roche AG.

Market Segmentation & Coverage

This research report categorizes the Allergy Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Drug Allergy, Food Allergy, and Inhaled Allergy.
• Based on Treatment, market is studied across Anti-allergy Drugs and Immunotherapy. The Anti-allergy Drugs is further studied across Antihistamines, Corticosteroids, and Leukotriene Inhibitors. The Immunotherapy is further studied across Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT).
• Based on Distribution Channels, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of allergy globally
    • 5.1.1.2. Increasing development of allergy-specific drugs
    • 5.1.1.3. Rise in prevalence towards over the counter drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns over patent expiration and extensive competition from generic drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of immunotherapy and development of increasing ways of administration
    • 5.1.3.2. Rising consumer awareness on food allergies
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative drugs for allergy
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Allergy Drugs Market, by Type

• 6.1. Introduction
• 6.2. Drug Allergy
• 6.3. Food Allergy
• 6.4. Inhaled Allergy

7. Allergy Drugs Market, by Treatment

• 7.1. Introduction
• 7.2. Anti-allergy Drugs
  • 7.2.1. Antihistamines
  • 7.2.2. Corticosteroids
  • 7.2.3. Leukotriene Inhibitors
• 7.3. Immunotherapy
  • 7.3.1. Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)

8. Allergy Drugs Market, by Distribution Channels

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Online Pharmacies
• 8.4. Retail Pharmacies & Drug Stores

9. Americas Allergy Drugs Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Allergy Drugs Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Allergy Drugs Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Allergy Therapeutics PLC
• 2. Astra Biotech GmbH
• 3. AstraZeneca PLC
• 4. Bayer AG
• 5. GlaxoSmithKline PLC
• 6. HAL Allergy B.V.
• 7. Hikma Pharmaceuticals PLC
• 8. Johnson & Johnson Services, Inc.
• 9. LETI Pharma, S.L.U.
• 10. Lupin Limited
• 11. Mylan N.V. by Viatris Inc.
• 12. Novartis AG
• 13. Sanofi SA
• 14. Teva Pharmaceutical Industries Ltd.
• 15. XOLAIR by F. Hoffmann-La Roche AG